How Do Fatty Acids Cause Allosteric Binding of Drugs to Human Serum Albumin?

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2002 Nov 12

PMID 12425462

Citations 15

Authors

Victor Tuan Giam Chuang

Masaki Otagiri

Affiliations

Soon will be listed here.

Abstract

Purpose: This study was undertaken to investigate how fatty acids cause the allosteric binding of drugs to human serum albumin (HSA). The influence of fatty acids on the binding of ketoprofen (KP), an NSAID, to HSA was examined by using a photoaffinity labeling technique.

Methods: Ultrafiltration was performed to quantitate the concentration of free KP. HSA, photolabeled with KP in the presence of myristate (MYR), octanoate, and diazepam, was cleaved with cyanogen bromide, separated by Tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis and subsequently analyzed by autoradiography.

Results: The addition of MYR at molar ratios from 4 to 5, but not from 1 to 2, causes substantial increases in unbound KP for KP:HSA ratios of 0.5 and 1. The addition of two or more moles of MYR, octanoate, and diazepam per mole of HSA caused a pronounced decrease in the labeling of the 11.6- and 13.5-kDa peptides. However, only MYR showed an increase in labeling of the 20 kDa and, especially, the 9.4-kDa peptides. At MYR:HSA ratios in excess of 3, a decrease in the extent of labeling of the 9.4-kDa peptide was observed.

Conclusion: Long-chain fatty acids regulate the binding properties of HSA in a complex manner, in which a simultaneous competitive and allosteric mechanism operates and which mainly involves domain I.

Citing Articles

Heme Scavenging and Delivery: The Role of Human Serum Albumin.

De Simone G, Varricchio R, Ruberto T, Di Masi A, Ascenzi P Biomolecules. 2023; 13(3).

PMID: 36979511 PMC: 10046553. DOI: 10.3390/biom13030575.

Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural-Chemical Investigation.

Hirata K, Kawai A, Chuang V, Sakurama K, Nishi K, Yamasaki K ACS Omega. 2022; 7(5):4413-4419.

PMID: 35155934 PMC: 8829929. DOI: 10.1021/acsomega.1c06220.

The Interplay between Non-Esterified Fatty Acids and Plasma Zinc and Its Influence on Thrombotic Risk in Obesity and Type 2 Diabetes.

Hierons S, Marsh J, Wu D, Blindauer C, Stewart A Int J Mol Sci. 2021; 22(18).

PMID: 34576303 PMC: 8471329. DOI: 10.3390/ijms221810140.

Albumin in patients with liver disease shows an altered conformation.

Paar M, Fengler V, Rosenberg D, Krebs A, Stauber R, Oettl K Commun Biol. 2021; 4(1):731.

PMID: 34127764 PMC: 8203801. DOI: 10.1038/s42003-021-02269-w.

Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Czub M, Handing K, Venkataramany B, Cooper D, Shabalin I, Minor W J Med Chem. 2020; 63(13):6847-6862.

PMID: 32469516 PMC: 7902233. DOI: 10.1021/acs.jmedchem.0c00225.

References

Rahman M, Yamasaki K, Shin Y, Lin C, Otagiri M . Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin. Biol Pharm Bull. 1993; 16(11):1169-74. DOI: 10.1248/bpb.16.1169. View

Hamilton J, Era S, Bhamidipati S, Reed R . Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci U S A. 1991; 88(6):2051-4. PMC: 51166. DOI: 10.1073/pnas.88.6.2051. View

Vorum H, Honore B . Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J Pharm Pharmacol. 1996; 48(8):870-5. DOI: 10.1111/j.2042-7158.1996.tb03990.x. View

Petitpas I, Bhattacharya A, Twine S, East M, Curry S . Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J Biol Chem. 2001; 276(25):22804-9. DOI: 10.1074/jbc.M100575200. View

Rietbrock N, Menke G, Reuter G, Lassmann A, Schmeidl R . Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies. J Clin Chem Clin Biochem. 1985; 23(11):719-23. DOI: 10.1515/cclm.1985.23.11.719. View

Kragh-Hansen U . Structure and ligand binding properties of human serum albumin. Dan Med Bull. 1990; 37(1):57-84. View

Spector A . Fatty acid binding to plasma albumin. J Lipid Res. 1975; 16(3):165-79. View

Dockal M, Carter D, Ruker F . The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999; 274(41):29303-10. DOI: 10.1074/jbc.274.41.29303. View

Kragh-Hansen U . Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin. Biochem J. 1991; 273 ( Pt 3):641-4. PMC: 1149812. DOI: 10.1042/bj2730641. View

10.

Eckenhoff R, PETERSEN C, Ha C, Bhagavan N . Inhaled anesthetic binding sites in human serum albumin. J Biol Chem. 2000; 275(39):30439-44. DOI: 10.1074/jbc.M005052200. View

11.

Curry S, Mandelkow H, Brick P, Franks N . Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998; 5(9):827-35. DOI: 10.1038/1869. View

12.

Wanwimolruk S, Birkett D, Brooks P . Structural requirements for drug binding to site II on human serum albumin. Mol Pharmacol. 1983; 24(3):458-63. View

13.

Wilding G, Feldhoff R, Vesell E . Concentration-dependent effects of fatty acids on warfarin binding to albumin. Biochem Pharmacol. 1977; 26(12):1143-6. DOI: 10.1016/0006-2952(77)90058-2. View

14.

Brown N, Wilson A, Bridges J . Chain length dependency of fatty acid and carbamate binding to serum albumin. Biochem Pharmacol. 1982; 31(24):4019-29. DOI: 10.1016/0006-2952(82)90650-5. View

15.

Curry S, Brick P, Franks N . Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim Biophys Acta. 1999; 1441(2-3):131-40. DOI: 10.1016/s1388-1981(99)00148-1. View

16.

Takamura N, Maruyama T, Otagiri M . Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. Clin Chem. 1998; 43(12):2274-80. View

17.

Bhattacharya A, Grune T, Curry S . Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol. 2000; 303(5):721-32. DOI: 10.1006/jmbi.2000.4158. View

18.

Chuang V, Kuniyasu A, Nakayama H, Matsushita Y, Hirono S, Otagiri M . Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. Biochim Biophys Acta. 1999; 1434(1):18-30. DOI: 10.1016/s0167-4838(99)00174-0. View

19.

Eckenhoff R . Amino acid resolution of halothane binding sites in serum albumin. J Biol Chem. 1996; 271(26):15521-6. DOI: 10.1074/jbc.271.26.15521. View

20.

Hamilton J, Cistola D, Morrisett J, Sparrow J, Small D . Interactions of myristic acid with bovine serum albumin: a 13C NMR study. Proc Natl Acad Sci U S A. 1984; 81(12):3718-22. PMC: 345290. DOI: 10.1073/pnas.81.12.3718. View